Expression of cyclin D1 in normal, hyperplastic and neoplastic endometrium and its correlation with Ki-67 and clinicopathological variables

Archives of Gynecology and Obstetrics

Volumn 271, Issue 2, 2005, Pages 123-126

  Özuysal, Sema ^a   Öztürk, Hülya ^a   Bilgin, Tufan ^a   Filiz, Gülaydan ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

Carcinogenesis; Cyclin D1; Endometrial cancer; Endometrial hyperplasia; Ki67

Indexed keywords

CYCLIN D1; KI 67 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER SURVIVAL; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; PROTEIN EXPRESSION; STATISTICAL ANALYSIS;

BIOLOGICAL MARKERS; CARCINOMA, ENDOMETRIOID; CELL PROLIFERATION; CYCLIN D1; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; HUMANS; KI-67 ANTIGEN; MIDDLE AGED;

EID: 16444379378     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00404-003-0595-5     Document Type: Article

References (20)

1. Barbieri F, Cagnoli M, Ragni N, Foglia G, Bruzzo C, Pedulla F, Alama A (1999) Increased cyclin-D1 expression is associated with features of malignancy and disease recurrence in ovarian tumors. Clin Cancer Res 5:1837-1842
2. Bartek J, Lukas J, Bartkova J (1999) Perspective: defects in cell cycle control and cancer. J Pathol 187:95-99
3. Cao QJ, Einstein MH, Anderson PS, Runowicz CD, Balan R, Jones JG (2002) Expression of COX-2, Ki-67, cyclin-D1, and P21 in endometrial endometrioid carcinomas. Int J Gynecol Pathol 21:141-146
4. Caputi M, De Luca L, Papaccio G, D'Aponte A, Cavallotti I, Scala P, Scarano F, Manna M, Gualdiero L, De Luca B (1997) Prognostic role of cyclin-D1 in non small cell lung cancer: an immunohistochemical analysis. Eur J Histochem 41:133-138
5. Courjal F, Louason G, Speiser P, Katsaros D, Zeillinger R, Theillet C (1996) Cyclin gene amplification and overexpression in breast and ovarian cancers: evidence for the selection of cyclin-D1 in breast and cyclin E in ovarian tumors. Int J Cancer 69:247-253
6. Hung WC, Chai CY, Huang JS, Chuang LY (1996) Expression of cyclin-D1 and c-Ki-ras gene product in human epithelial ovarian tumors. Hum Pathol 27:1324-1328
7. Hunter T, Pines J (1991) Cyclins and cancer. Cell 66:1071-1074
8. Itami A, Shimada Y, Watanabe G, Imamura M (1999) Prognostic value of p27 (Kip1) and cyclin-D1 expression in esophageal cancer. Oncology 57:311-317
9. Ito K, Sasano H, Yoshida Y, Sato S, Yajima A (1998) Immunohistochemical study of cyclins D and E and cyclin dependent kinase (cdk) 2 and 4 in human endometrial carcinoma. Anticancer Res 18:1661-1664
10. Kornmann M, Ishiwata T, Itakura J, Tangvoranuntakul P, Beger HG, Korc M (1998) Increased cyclin-D1 in human pancreatic cancer is associated with decreased postoperative survival. Oncology 55:363-369
11. Lukas J, Muller H, Bartkova J, Spitkovsky D, Kjerulff AA, Jansen-Durr P, Strauss M, Bartek JJ (1994) DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin-D1 function in G1. Cell Biol 125:625-638
12. Niehans GA, Kratzke RA, Froberg MK, Aeppli DM, Nguyen PL, Geradts J (1999) G1 checkpoint protein and p53 abnormalities occur in most invasive transitional cell carcinomas of the urinary bladder. Br J Cancer 80:1175-1184
13. Nikaido T, Li SF, Shiozawa T, Fujii S (1996) Coabnormal expression of cyclin-D1 and p53 protein in human uterine endometrial carcinomas. Cancer 78:1248-1253
14. Opitz OG, Suliman Y, Hahn WC, Harada H, Blum HE, Rustgi AK (2001) Cyclin-D1 overexpression and p53 inactivation immortalize primary oral keratinocytes by a telomerase-independent mechanism. J Clin Invest 108:665-667
15. Ruhul Quddus M, Latkovich P, Castellani WJ, James Sung C, Steinhoff MM, Briggs RC, Miranda RN (2002) Expression of cyclin-D1 in normal, metaplastic, hyperplastic endometrium and endometrioid carcinoma suggests a role in endometrial carcinogenesis. Arch Pathol Lab Med 126:459-463
16. Soslow RA, Shen PU, Chung MH, Isacson C, Baergen RN (2000) Cyclin-D1 expression in high-grade endometrial carcinomas: association with histologic subtype. Int J Gynecol Pathol 19:329-334
17. Tsuda H, Yamamoto K, Inoue T, Uchiyama I, Umesaki N (2000) The role of p16-cyclin d/CDK-pRb pathway in the tumorigenesis of endometrioid-type endometrial carcinoma. Br J Cancer 82:675-682
18. Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A, Schmidt EV (1994) Mammary hyperplasia and carcinoma in MMTV-cyclin-D1 transgenic mice. Nature 369:669-671
19. Worsley SD, Ponder BA, Davies BR (1997) Overexpression of cyclin-D1 in epithelial ovarian cancers. Gynecol Oncol 64:189-195
20. Zukerberg LR, Yang WI, Gadd M, Thor AD, Koerner FC, Schmidt EV, Arnold A (1995) Cyclin-D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin-D1 oncogene. Mod Pathol 8:560-567